Medroxyprogesterone Acetate and Bone Density in Adolescents.

机译：青少年醋酸甲羟孕酮和骨密度。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

The purpose of this research is to determine if the young female's use of DMPA affects bone remodeling. 60 participants, age 14-21, will be followed at zero, three, six, nine and 12 months. Dual energy x-ray absorbtiometry will be used to obtain BMD at the initial visit and at six-month intervals. Blood samples for cross-linked N-telopeptides, estradiol and dihydroepiandrostendione sulfate (DHEAS) will be obtained prior to initiation of DMPA and every 12 weeks prior to each DMPA injection. Exploratory analysis will be used to examine the overall sample and individual pattern of BMD and biochemical variables. Sign tests will be performed in which individual's measures at 6 and 12 months are compared to their baseline level. Descriptive statistics will be used to describe age, race, socioeconomic status, height, weight, body mass index (BMI), calcium intake, physical activity, tobacco and alcohol use. This information will be obtained during a structured interview.

著录项

作者
Shireman, C. L.;
展开▼
作者单位

展开▼
年度 2005
页码 1-30
总页数 30
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Bones; Density; Adolescents; Age; Blood samples; Body mass index; Calcium; Females; Height; Physical activities; Race; Weight; Medroxyprogesterone acetate;

机译：骨骼;密度;青少年;年龄;血液样本;体重指数;钙;女性;身高;体力活动;种族;体重;醋酸甲羟孕酮;

相似文献

外文文献
中文文献
专利

1. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density. [J] . Walsh JS, Eastell R, Peel NF Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2010,第3期

机译：峰值骨量后使用乙酸甲羟孕酮与增加骨转换有关，但不会降低骨矿物质密度。
2. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density. [J] . Johnson CC, Burkman RT, Gold MA, Contraception . 2008,第4期

机译：醋酸甲羟孕酮（Depo-Provera）对青少年骨骼健康影响的纵向研究：研究设计，人群特征和基线骨矿物质密度。
3. Bone Mineral Density in Antiretroviral Therapy‐Na?ve HIV‐1–Infected Young Adult ‐Women Using Depot Medroxyprogesterone Acetate or Nonhormonal Contraceptives in Uganda [J] . Flavia Kiweewa Matovu, Martin Nabwana, Noah Kiwanuka, JBMR plus. . 2021,第2期

机译：抗逆转录病毒治疗中的骨密度-NA？VE HIV-1感染的年轻成人 - 乌干达中甲酸甲酸盐酸盐酮酸盐或非激烈避孕药
4. Simultaneous Determination of Medroxyprogesterone Acetate, Progesterone and Allopregnanolone in Rat Serum by Liquid Chromatography-Tandem Mass Spectrometry [C] . Xiaoqian Liu, Petr Frycak, Heather Bimonte-Nelson, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：通过液相色谱 - 串联质谱法同时测定大鼠血清中大鼠血清中的丙酮，孕酮和亚丙醇
5. The Potential for Intramuscular Depot Medroxyprogesterone Acetate as a Self-Bridging Emergency Contraceptive [D] . Schickler, Robyn. 2019

机译：肌肉内贮库中甲基蛋白质的潜力作为自我桥接紧急避孕药
6. Health and Drug Alerts: Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss [O] . Eric Wooltorton 2005

机译：健康和药物警报：醋酸甲羟孕酮（Depo-Provera）和骨矿物质密度损失
7. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and oral contraceptives and depot-medroxyprogesterone acetate for contraception. Wanichsetakul P, Kamundhamas A, Watanaruangkovit P, et al.Contraception 2002; 65: 407-410 [O] . Judy Murty 2003

机译：在接受口服避孕药和口服避孕药和口服避孕药和储存的妇女的妇女中的骨密度和口服避孕药乙酸酯进行避孕。 Wanichsetakul P，Kamundhamas A，Watanaruangkovit P，等人。避孕 2002; 65：407-410

Medroxyprogesterone Acetate and Bone Density in Adolescents.

摘要

著录项

相似文献

相关主题

期刊订阅